| Code | Description | Claims | Beneficiaries | Total Paid |
| 77014 |
|
54,197 |
16,181 |
$3.21M |
| 77386 |
|
15,287 |
4,994 |
$2.61M |
| 99215 |
Prolong outpt/office vis |
20,880 |
12,194 |
$756K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,554 |
10,784 |
$383K |
| 77427 |
|
4,521 |
1,726 |
$292K |
| 77336 |
|
6,910 |
3,975 |
$217K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
1,679 |
790 |
$157K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
5,506 |
2,263 |
$154K |
| 77412 |
|
1,149 |
402 |
$104K |
| 77334 |
|
863 |
609 |
$81K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,743 |
3,204 |
$69K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
812 |
589 |
$45K |
| G6015 |
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session |
3,300 |
1,048 |
$37K |
| 77385 |
|
191 |
65 |
$36K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
1,723 |
799 |
$33K |
| 77301 |
|
85 |
57 |
$32K |
| 99205 |
Prolong outpt/office vis |
495 |
439 |
$31K |
| 77290 |
|
203 |
169 |
$28K |
| 77300 |
|
354 |
283 |
$22K |
| 80053 |
Comprehensive metabolic panel |
3,565 |
2,446 |
$21K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,817 |
2,618 |
$17K |
| 77263 |
|
165 |
134 |
$11K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
156 |
150 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
8,924 |
5,879 |
$9K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
182 |
135 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
125 |
125 |
$7K |
| 99233 |
Prolong inpt eval add15 m |
199 |
54 |
$7K |
| 77338 |
|
42 |
38 |
$7K |
| 99223 |
Prolong inpt eval add15 m |
121 |
90 |
$6K |
| 82728 |
|
639 |
554 |
$5K |
| 99195 |
|
124 |
100 |
$5K |
| 96417 |
|
191 |
83 |
$4K |
| 83550 |
|
593 |
522 |
$3K |
| 82378 |
|
273 |
203 |
$3K |
| 80050 |
General health panel |
92 |
83 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
380 |
319 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
711 |
353 |
$2K |
| 83540 |
|
594 |
523 |
$2K |
| 83615 |
|
471 |
407 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
86 |
79 |
$1K |
| 96415 |
|
100 |
51 |
$1K |
| 96411 |
|
59 |
26 |
$1K |
| 96416 |
|
28 |
12 |
$1K |
| 83735 |
|
152 |
101 |
$725.66 |
| 96367 |
|
903 |
353 |
$716.24 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,748 |
1,192 |
$650.86 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,964 |
692 |
$579.38 |
| 84153 |
|
76 |
71 |
$536.19 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
75 |
24 |
$513.19 |
| 96402 |
|
65 |
51 |
$499.17 |
| 82607 |
|
59 |
50 |
$421.21 |
| 84403 |
|
31 |
29 |
$403.49 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
663 |
268 |
$355.19 |
| 77370 |
|
16 |
12 |
$329.68 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
415 |
237 |
$197.03 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
444 |
146 |
$188.17 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
158 |
114 |
$66.52 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
29 |
25 |
$42.71 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
26 |
14 |
$20.34 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
47 |
26 |
$16.44 |
| 96523 |
|
89 |
56 |
$9.35 |
| J3490 |
Unclassified drugs |
19 |
13 |
$3.00 |